Ankylosing Spondylitis

Latest News

Assessing Diagnostic Challenges in Axial Spondyloarthritis

Assessing Diagnostic Challenges in Axial Spondyloarthritis

Axial spondyloarthritis is often delayed or missed as a diagnosis, leading to poor long-term outcomes and decreased quality of life.

Pelvic Orientation From Standing to Sitting Adjusted by Global Spinal Alignment in AS

Pelvic Orientation From Standing to Sitting Adjusted by Global Spinal Alignment in AS

Pelvic orientation was adjusted by global spinal alignment in patients with ankylosing spondylitis.

Work Instability Linked to Fatigue, Depression in Ankylosing Spondylitis

Work Instability Linked to Fatigue, Depression in Ankylosing Spondylitis

Fatigue and depressive symptoms had a negative effect on work stability in patients with ankylosing spondylitis.

Acute Anterior Uveitis Incidence Reduced With Golimumab in Ankylosing Spondylitis

Acute Anterior Uveitis Incidence Reduced With Golimumab in Ankylosing Spondylitis

Researchers observed a significant reduction in the incidence of acute anterior uveitis among patients with ankylosing spondylitis treated with golimumab.

CRP Levels May Predict Treatment Response in Ankylosing Spondylitis

CRP Levels May Predict Treatment Response in Ankylosing Spondylitis

C-reactive protein levels may be an effective predictive measure to assess treatment response in patients with ankylosing spondylitis.

Filgotinib Safe, Effective for Treatment of Active Ankylosing Spondylitis

Filgotinib Safe, Effective for Treatment of Active Ankylosing Spondylitis

The TORTUGA trial investigated the efficacy and safety of filgotinib for the treatment of patients with active ankylosing spondylitis.

Clinical Characteristics of Patients With AS Who Discontinue TNFis Explored

Clinical Characteristics of Patients With AS Who Discontinue TNFis Explored

To compare the characteristics of patients who discontinued TNFis with those who did not, researchers used the Corrona PsA/SpA Registry to identify patients with AS who were on a TNFi and had ≥2 follow-up visits.

Differences in Ankylosing Spondylitis Outcomes Vary by Gender

Differences in Ankylosing Spondylitis Outcomes Vary by Gender

Clinical improvements during treatment with TNF-α inhibitors was comparable between men and women with ankylosing spondylitis.

Sustained Improvements in Quality of Life With Secukinumab in Ankylosing Spondylitis

Sustained Improvements in Quality of Life With Secukinumab in Ankylosing Spondylitis

Treatment with secukinumab 150 mg provides significant, clinically meaningful, and sustained improvement in health-related quality of life among patients with ankylosing spondylitis.

Genetic Risk Score May Lead to Earlier Ankylosing Spondylitis Diagnosis

Genetic Risk Score May Lead to Earlier Ankylosing Spondylitis Diagnosis

The genetic risk score may have lower costs than current testing methods.

Sign Up for Free e-newsletters